|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.3 TWD | +1.47% |
|
+1.47% | -18.86% |
Senhwa Biosciences, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 1 million compared to TWD 1 million a year ago. Net loss was TWD 296.31 million compared to TWD 349.63 million a year ago.
Basic loss per share from continuing operations was TWD 3.32 compared to TWD 3.92 a year ago. Diluted loss per share from continuing operations was TWD 3.32 compared to TWD 3.92 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.86% | 111M | |
| -2.34% | 103B | |
| +1.78% | 95.28B | |
| +1.46% | 22.15B | |
| -15.57% | 21.02B | |
| -8.58% | 18.15B | |
| -38.74% | 16.73B | |
| -13.01% | 16.05B | |
| +5.33% | 13.68B | |
| +34.70% | 12.17B |
SENHWA BIOSCIENCES, INC. 
